Top 10 Companies in the Global Vials Market (2026): Leaders Shaping Packaging for Biopharma

MARKET INSIGHTS

Global vials market size was valued at USD 4.23 billion in 2024. The market is projected to grow from USD 4.56 billion in 2025 to USD 7.18 billion by 2032, exhibiting a CAGR of 6.8% during the forecast period.

Vials are small containers, typically made of glass or plastic, designed to store liquids, powders, or other pharmaceutical and chemical substances securely. These containers play a critical role in industries such as healthcare, personal care, and chemicals due to their ability to maintain product integrity and prevent contamination. Glass vials dominate the market because of their inert properties, while plastic variants are gaining traction for their lightweight and cost‑effective nature.

The market is expanding due to rising demand for pharmaceutical packaging, particularly for vaccines and biologics, as well as increasing investments in healthcare infrastructure. Additionally, stringent regulatory standards for drug safety and storage are propelling the adoption of high‑quality vials. Key players like Gerresheimer and Schott AG are innovating with advanced materials and sustainable solutions, further driving market growth. The Asia‑Pacific region is expected to witness the fastest growth, fueled by expanding pharmaceutical manufacturing and rising healthcare expenditure.

Global Vials Market – View in Detailed Research Report

🔟 1. Gerresheimer

Headquarters: Darmstadt, Germany
Key Offering: High‑precision glass vials, custom dispensing solutions, and integrated filling lines

Gerresheimer has built a reputation for delivering sterile, high‑quality glass containers that meet the stringent requirements of biopharmaceutical manufacturers. Its portfolio spans from small‑volume vaccine vials to large‑capacity biologics, and the company continuously upgrades its glass‑blowing technology to reduce breakage and enhance sterilization efficiency.

Sustainability & Growth Initiatives:

• Investment in low‑extractable glass formulations to minimize leachables
• Partnerships with vaccine producers to co‑develop next‑generation vial lines
• Commitment to circular economy through recycling of glass waste

9️⃣ 2. Schott AG

Headquarters: Mainz, Germany
Key Offering: Advanced glass solutions, high‑temperature resistant vials, and automation systems

Schott AG leverages its expertise in glass chemistry to produce vials that withstand the rigorous demands of biologics and gene therapies. The firm integrates smart features such as RFID tags and tamper‑evident seals into its product line, positioning itself as a technology partner for global vaccine manufacturers.

Sustainability & Growth Initiatives:

• Development of borosilicate glass with reduced environmental impact
• Collaboration with research institutes to improve sterilization processes
• Investment in renewable energy for production facilities

8️⃣ 3. Berry Global

Headquarters: St. Louis, United States
Key Offering: Plastic vials, composite containers, and automated fill‑finish solutions

Berry Global supplies a wide array of single‑use plastic vials that cater to the fast‑paced demand of vaccine and biologic manufacturers. Its focus on lightweight materials and cost efficiency has made it a preferred supplier for companies seeking to balance performance with budget constraints.

Sustainability & Growth Initiatives:

• Launch of recyclable plastic vial lines
• Optimization of manufacturing processes to cut energy consumption
• Partnerships with packaging recyclers to close the loop

7️⃣ 4. West Pharmaceutical Services

Headquarters: West Chester, United States
Key Offering: Composite vials, advanced fill‑finish equipment, and process automation

West Pharmaceutical Services delivers end‑to‑end solutions that enable manufacturers to scale up production of biologics and vaccines while maintaining strict sterility standards. Its equipment portfolio supports high‑throughput filling and aseptic processing.

Sustainability & Growth Initiatives:

• Implementation of lean manufacturing to reduce waste
• Research into biodegradable coatings for vial closures
• Investment in digital twin technology for process optimization

6️⃣ 5. Adelphi Healthcare Packaging

Headquarters: London, United Kingdom
Key Offering: High‑value glass vials for oncology and rare‑disease biologics

Adelphi focuses on niche, low‑volume vials that meet the stringent sterility and compatibility requirements of oncology and rare‑disease products. The company emphasizes rapid turnaround and high‑purity manufacturing to support time‑critical clinical trials.

Sustainability & Growth Initiatives:

• Adoption of closed‑loop sterilization processes
• Collaboration with pharmaceutical developers to co‑create tailored vial solutions
• Commitment to reducing single‑use plastic consumption

5️⃣ 6. Nipro Corporation

Headquarters: Tokyo, Japan
Key Offering: Glass and plastic vials, specialized cap solutions, and supply‑chain integration

Nipro serves both mature and emerging markets with a diverse product range, supported by strategic plant locations across Asia. Its focus on quality control and regulatory compliance has positioned it as a trusted supplier for vaccine manufacturers.

Sustainability & Growth Initiatives:

• Implementation of ISO 14001 environmental management
• Development of low‑impact packaging materials
• Participation in regional biopharma park initiatives

4️⃣ 7. Bormioli Pharma

Headquarters: Bologna, Italy
Key Offering: Glass vials for pharmaceutical and laboratory applications

Bormioli Pharma offers a wide range of glass containers tailored to laboratory and industrial needs. The company’s emphasis on precision engineering supports high‑throughput testing and research activities.

Sustainability & Growth Initiatives:

• Investment in energy‑efficient glass furnaces
• Collaboration with academic partners on material science research
• Promotion of recycling programs for end‑of‑life vials

3️⃣ 8. Stevanato Group

Headquarters: Reggio Emilia, Italy
Key Offering: Specialty glass manufacturing and syringe solutions

Stevanato has expanded its portfolio beyond syringes to include specialty glass vials that support a range of sterile products. The company’s acquisitions of niche facilities have broadened its capability to deliver customized solutions.

Sustainability & Growth Initiatives:

• Adoption of sustainable glassblowing techniques
• Partnerships with OEMs to co‑develop next‑generation containers
• Focus on reducing carbon footprint across production lines

2️⃣ 9. Pacific Vial Manufacturing

Headquarters: Singapore
Key Offering: Cost‑effective plastic vials for single‑use applications

Pacific Vial Manufacturing supplies the Asia‑Pacific region with plastic vials that meet emerging regulatory expectations for sterility and traceability. Its production model emphasizes scalability and rapid deployment for vaccine manufacturers.

Sustainability & Growth Initiatives:

• Launch of recyclable plastic vial lines in Southeast Asia
• Collaboration with local recyclers to establish closed‑loop systems
• Investment in process automation to lower material waste

1️⃣ 10. APG Pharma Packaging

Headquarters: New York, United States
Key Offering: High‑value glass vials for specialty biologics

APG Pharma Packaging delivers customized glass vials that meet the demanding specifications of specialty biologics. The firm focuses on rapid prototyping, certification, and delivery to support clinical development pipelines.

Sustainability & Growth Initiatives:

• Implementation of green chemistry in glass formulation
• Partnerships with biotech companies for co‑development
• Commitment to reducing packaging waste through design optimization

Download FREE Sample Report

Global Vials Market – View in Detailed Research Report

📈 Market Outlook 2025‑2034

Global vials demand is set to move from USD 4.56 billion in 2025 to an estimated USD 7.5 billion by 2034, reflecting a steady upward trajectory driven by expanding vaccine programs, biologics pipelines, and heightened regulatory focus on sterility.

🔮 Future Trends

• Adoption of single‑dose vials to eliminate cross‑contamination and streamline distribution.
• Integration of RFID and smart‑sensor technology for end‑to‑end traceability.
• Shift toward recyclable and lightweight materials to meet sustainability mandates.
• Growth of personalized and cell‑based therapies demanding low‑volume, high‑purity vial solutions.
• Digitalization of manufacturing processes through AI‑driven quality control and process optimization.